407 search results for “team immune responses” in the Staff website
-
Kiki SpaninksFaculty of Science
k.spaninks@biology.leidenuniv.nl | 071 5274835
-
Brigitte TheeuwesICLON
b.c.theeuwes@iclon.leidenuniv.nl | 071 5273855
-
Miyuki KerkhofHonours Academy
m.j.h.kerkhof@ha.leidenuniv.nl | 071 5271205
-
Manolis FragkiadakisFaculty of Humanities
m.fragkiadakis@hum.leidenuniv.nl | 071 5278059
-
Over €900,000 for new atherosclerosis treatment
How can we slow the progression of atherosclerosis? Researcher Amanda Foks believes the answer may be switching off ageing immune cells. This could lead to an entirely new treatment for heart attacks and strokes. She has been awarded an Established Investigator Dekker Grant by the Dutch Heart Founda…
-
Why stress could be good for you
Acute stress seems to have a surprisingly positive effect on our health. Researcher Erin Faught received an NWO veni grant to find out why that is and how we can use that knowledge to our advantage. For her lab research, she uses a remarkable small animal to learn more about our own stress levels.
-
ERC-subsidie om uit te zoeken hoe kinderen luchtweginfecties te lijf gaan
De crèche en het klaslokaal zijn misschien wel de meest gunstige plekken voor ziekteverwekkers. Toch is er relatief weinig bekend over hoe kinderen reageren op virussen en bacteriën en hoe het komt dat sommige kinderen veel beter beschermd zijn dan anderen. Simon Jochems, onderzoeker aan het Leids Universitair…
-
LRSN Workshop: Responsible Collaborations & Research Support
Course, Worksop
-
Why arteriosclerosis looks like an autoimmune disease
Arteriosclerosis bears great similarities to autoimmune diseases. Researchers from Leiden University show this in a new study they published in the renowned scientific journal Nature Cardiovascular Research. 'This discovery suggests that treatment methods for autoimmune diseases might also be effective…
-
The molecular secrets of medicinal cannabis
Chronic pain, nausea or vomiting due to chemotherapy. If you suffer from such ailments, medicinal cannabis can be a godsend. Though a downside is that it can make patients high. Therefore, Leiden researchers from the Oncode Institute are investigating alternatives that do not make you high. In Nature…
-
Making the invisible visible with ‘click chemistry’
Sander van Kasteren (Professor of Molecular Immunology) makes the invisible visible. He will explain more in his inaugural lecture.
-
Recent PhD defenses
Here we highlight the achievements of our latest PhD graduates, each of whom has made significant contributions to the advancement of the field of (bio)pharmaceutical sciences.
-
LUMC researchers use viruses to fight prostate cancer
Modified viruses can both kill cancer cells and activate the immune system. This is what an LUMC team discovered while researching a new prostate cancer therapy.
-
Scott Engels wins the Suzanne Hovinga Award 2022
During the LACDR Fall Symposium, Scott Engels received the Suzanne Hovinga Award for the ‘best master thesis’. Scott performed his RP1 research under the supervision of Dr. Amanda Foks and Virginia Smit in the Aging and Immunity group at the division of BioTherapeutics.
-
Doctors discover a simple method to predict the risk of brain tumour recurrence
The risk of a brain tumour recurring can be predicted more accurately by counting the number of immune cells in the tumour under a microscope. These are the findings from research conducted by LUMC, Erasmus MC and Heidelberg University.
-
LUMC researchers: high levels of lipids in blood protect against allergies
People with relatively high levels of lipids in their blood are less likely to develop allergic conditions such as eczema and asthma. These lipids cause genes that play a key role in allergic reactions to be less active. Researchers from the Leiden University Medical Center (LUMC) have published an…
-
Koos van der HoevenFaculty of Medicine
j.j.m.van.der.hoeven@lumc.nl | 071 5269111
-
Jaap Jan ZwagingaFaculty of Medicine
j.j.zwaginga@lumc.nl | 071 5269111
-
Catherine MergenFaculty of Science
c.mergen@lacdr.leidenuniv.nl | 071 5276038
-
Fijs van LeeuwenFaculty of Medicine
f.w.b.van_leeuwen@lumc.nl | 071 5269111
-
Jan van LithFaculty of Medicine
j.m.m.van_lith@lumc.nl | 071 5262896
-
Willem FibbeFaculty of Medicine
w.e.fibbe@lumc.nl | 071 5262271
-
Bart van HoekFaculty of Medicine
b.van_hoek@lumc.nl | 071 5269111
-
Amir ZadpoorFaculty of Medicine
a.a.zadpoor@tudelft.nl | 071 5269111
-
Manfred WuhrerFaculty of Medicine
m.wuhrer@lumc.nl | 071 5269111
-
Frank StaalFaculty of Medicine
f.j.t.staal@lumc.nl | 071 5263800
-
Henricus VerspagetFaculty of Medicine
h.w.verspaget@umail.leidenuniv.nl |
-
Marloes van OosterhoutFaculty of Science
l.p.j.van.oosterhout@lacdr.leidenuniv.nl | 071 5271031
-
Sjaak NeefjesFaculty of Medicine
j.j.c.neefjes@lumc.nl | 071 5263800
-
Jort van der LaanFaculty of Humanities
j.d.van.der.laan@kunsten.leidenuniv.nl | 071 5272727
-
Marie DepuydtFaculty of Science
m.a.c.depuydt@lacdr.leidenuniv.nl | 071 5276051
-
Shunning Responsibilities and Shifting Risks: States’ Responses to the Foreign Terrorist Fighters Phenomenon & the Limits of Public International
PhD defence
-
How bittersweet sugar chemistry targets pathogens
The challenge is considerable, but so is the satisfaction when it succeeds: creating complex sugar molecules that play a role in biology.
-
Improving the treatment of pathogenic fungi. ‘The process is working, but not that well…’
Fungi germinating in the lungs of patients. Doesn’t sound too nice, does it? Luckily, humans can deal with this normally, and we are able to clear the infection before anything comes to harm. However, in people with health issues, Aspergillosis can cause a lot of damage, especially if the fungus becomes…
-
How Leiden University is taking action against cancer
One in two people will be diagnosed with cancer. World Cancer Day on 4 February raises awareness of the impact of this devastating disease. Leiden University is conducting various studies aimed at preventing and controlling cancer. Below are just a few examples.
-
New easy-to-use tuberculosis vaccine patch in development
Researchers from Leiden have developed a promising TB vaccine that users can self-administer via a special patch. This could be beneficial for countries with limited health services, says PhD candidate Malene Neustrup.
-
Joey Zuijderveldt won first prize in the ‘Schild-De Groen Onderzoeksprijzen' for cancer research
One of our PhD candidates at the LACDR, Joey Zuijdervelt, recently achieved recognition by winning the first prize in the ‘Schild-De Groen Onderzoeksprijzen’ for cancer research. His award-winning master’s thesis explored glioblastoma multiforme through an innovative orthotopic zebrafish xenograft model,…
-
Chemistry as the key to medical innovation
Is it a coincidence that three chemists from the same department have each independently received a ZonMw grant? 'No,' the researchers agree in unison. 'The role of chemistry in medical biology is becoming increasingly important, and we’ve worked hard to make this happen.'
-
Interdisciplinary Collaboration Explores Substance P in Health and Disease
A team of LACDR scientists from three different divisions (SPP, BT, MC) contributed to a book on "Substance P in Health and Disease," which will be published by Elsevier. The project was a collaboration with Hannover Medical School (Germany) and was coordinated by Alireza Mashaghi. Master students Ehsan…
-
Stiffness and viscosity of cells differ in cancer and other diseases
During illness, the stiffness or viscosity of cells can change. Tom Evers demonstrated this by measuring such properties of human immune cells for the first time. ‘The stiffness of certain cells could be a way to make a diagnosis,’ Evers said. He defended his thesis on March 26th.
-
Better treatment of systemic autoimmune diseases requires close collaboration
Exceptional collaboration between physicians is needed to better understand and treat autoimmune diseases that cause inflammation in various organ systems.
-
Lettie DorstFaculty of Humanities
a.g.dorst@hum.leidenuniv.nl | 071 5273026
-
Iran at a Crossroads: Protest, Repression, and Europe’s Response
Debate
-
‘Cancer treatment should be a six-week life event’
When internist Christian Blank made his very first discovery, his field of immunotherapy was the underdog of cancer research. Now, over 20 years later, Blank has been appointed Professor By Special Appointment of Internal Medicine for his clinical research into immunotherapy and will give his inaugural…
-
Innovative Leiden research receives NWO grant
On January 24 Professor Annemarie Meijer and Dr Sander Wezenberg received a NWO grant for their research. The grant was awarded within the Open Competition Domaine Science-M programme and is intended for innovative research areas that can form the basis for the research themes of the future.
-
Moderator Trainings for Kaltura Live Room and MS Teams
ICT
-
Vidi grant for seven researchers from Leiden University
From malaria parasites as a vaccine to how top-level bureaucrats reach their decisions: seven researchers from Leiden University have received a Vidi grant from the Dutch Research Council (NWO). This 800,000-euro grant will enable them to develop their own innovative line of research over the next five…
-
New treatments for life-threatening disease sepsis
Due to the increasing resistance to certain antibiotics, the life-threatening condition sepsis is becoming harder to treat. For her PhD project, Leiden pharmacologist Feiyan Liu used mathematical modeling to find out how antibiotics can be used more effectively to cure sepsis.
-
Why you should publish negative data
As a bachelor student of Bio-Pharmaceutical Sciences, Femke Vlaswinkel wrote a research proposal she was allowed to carry out in her master’s BPS. Femke subsequently graduated with honors. Her research was published in the journal Scientific Reports, she won an award from the Dutch Pharmacy Society…
-
Four Leiden consortia awarded large NWO grants
No less than four Leiden research teams have been awarded a grant by NWO. On 27 July NWO honoured 21 applications in the Open Competition ENW-XL. NWO awards the grants to consortia in the exact and natural sciences who are doing unconnected fundamental research that is 'driven by curiosity'.